Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
ARCT.OQ - Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc at Barclays Global Healthcare Conference
Mar 16, 2023 / 01:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Company Representative, [1]
--------------------------------------------------------------------------------
Well, thank you to Barclays for the invitation to present in here in Miami. I'm happy to give an update of where Arcturus is. Arcturus Therapeutics is a messenger RNA therapeutics and vaccine company.
But we're based in San Diego, and we have about 180 employees. And we have 3 divisions of the company. We have a vaccine division, a liver division and a lung division that each have a flagship asset that leads each of those auxiliaries of the company.
Our OTC program is a rare liver disease. That's our flagship for the liver franchise. We have a CF program called ARCT-032 that leads our lung franchise. And we also have several partnerships, as you